본문으로 건너뛰기
← 뒤로

Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.

1/5 보강
Surgery today 📖 저널 OA 10.4% 2021: 0/1 OA 2022: 0/3 OA 2023: 0/2 OA 2024: 2/6 OA 2025: 2/45 OA 2026: 10/68 OA 2021~2026 2026 Vol.56(2) p. 133-143
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022.
I · Intervention 중재 / 시술
curative resection between 2007 and 2022
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three). [CONCLUSIONS] The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.

Kubouchi Y, Wada T, Yasuda R, Nozaka Y, Fujiwara W, Matsui S

📝 환자 설명용 한 줄

[PURPOSE] Spread through air spaces (STAS) is a poor prognostic factor for lung adenocarcinoma, particularly in patients undergoing limited resection, and its accurate prediction can improve the patie

이 논문을 인용하기

↓ .bib ↓ .ris
APA Kubouchi Y, Wada T, et al. (2026). Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.. Surgery today, 56(2), 133-143. https://doi.org/10.1007/s00595-025-03119-6
MLA Kubouchi Y, et al.. "Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.." Surgery today, vol. 56, no. 2, 2026, pp. 133-143.
PMID 40839175 ↗

Abstract

[PURPOSE] Spread through air spaces (STAS) is a poor prognostic factor for lung adenocarcinoma, particularly in patients undergoing limited resection, and its accurate prediction can improve the patient outcomes. This study evaluated the impact of STAS on the surgical outcomes and predictive factors.

[METHODS] We analyzed 511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022. STAS was assessed histologically, and logistic regression was used to identify the predictors. The recurrence-free and overall survival rates were also evaluated.

[RESULTS] Among the patients, 27.8% had STAS with significantly poor 5-year recurrence-free survival (65.6% vs. 88.5% in STAS-positive vs.-negative cases, respectively), particularly in patients treated with sublobar resection. STAS was an independent, poor prognostic factor for the recurrence-free survival in the sublobar group but not in the lobectomy group. Elevated serum carcinoembryonic antigen (≥ 5.8 ng/mL), consolidation tumor ratio (≥ 0.9), and SUVmax (≥ 2.3) were independent predictors. STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three).

[CONCLUSIONS] The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (2)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반